MedPharm Ltd has expanded its relationship with Novan Inc. through their new agreement, which will broaden the relationship to include development of formulations and selection of product candidates, cost-effective product target screening and the development of in vitro models focused on Novan’s nitric oxide product technology.   “MedPharm is delighted to be able to support Novan in advancing and broadening its product pipeline,” commented Eugene Ciolfi, MedPharm’s President & CEO. “Our new...